My spin;
1. Research interest in peptide libraries was getting so big they had to set up the Cambridge option.
2.Big Pharma patent expiry cliff/lack of blockbuster drugs- already well known providing external opportunities with companies like PYC.
3. Billions of "options" generated a process to speed up analysis from years to weeks.
4.New Discussions gathering momentum- anyone know which Pharma Company based in La Jolla, San Diego - sounds like clue.
Might have been a good decision to buy PYCO this morning. Sounds like a break out year 2011.
Thoughts everyone?
Ramses
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
-0.070(4.93%) |
Mkt cap ! $787.4M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.34 | $530.1K | 388.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 13033 | $1.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 96548 | 2 |
View Market Depth
| Last trade - 13.33pm 23/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |